Second round of gefitinib may be promising lung cancer therapy
Wednesday, January 13, 2010 - 05:42
in Health & Medicine
Patients with non-small cell lung cancer in whom treatment with gefitinib is ineffective often have limited options, but results of a new study suggest that retreating patients with the same drug could have a beneficial effect.